A drug that blocks dopamine D2 receptors reduces a patient's hallucinations but does nothing for his lack of motivation and flat emotion. How does the revised dopamine hypothesis explain this?
- Hallucinations are positive symptoms, linked to excess dopamine in the mesolimbic pathway.
- Blocking D2 receptors lowers that excess activity, so the hallucinations fade.
- Lack of motivation and flat emotion are negative symptoms, linked to too little dopamine in the prefrontal cortex.
- Blocking dopamine cannot correct a shortage, so these symptoms stay.
Answer: Positive symptoms come from too much dopamine (helped by blocking); negative symptoms come from too little in the prefrontal cortex (not helped by blocking).